We sincerely hope you are happy with the care you have received in our practice. As a means of reaching out to more patients like you in the community, we would like for you to vote for us in the Savannah Magazine Best Doctors 2024 poll.
Voting is easy! Click “Vote Now”, scroll down to #51, and vote for Dr. Richard R. Schulze, Jr., under the “Best Ophthalmologist” category in Savannah Magazine’s Best of Doctors 2024 Edition. It will take less than five minutes to complete. Please share this link and ask family and friends to vote as well! While you’re there, vote for your favorites in other specialties as well. Hurry, the voting ends on April 8th!
Thanks to all of you who voted for Dr. Schulze, he won 7 years in a row as Best Ophthalmologist (2017 – 2023)! We appreciate your trust in Dr. Schulze and would like to keep this streak going. Thank you for your help again this year! We look forward to serving you in 2024!
A magna cum laude graduate of Princeton University, Dr. Schulze went on to study English literature at Oxford University, receiving his M. Phil. degree, before graduating with his M.D. from the University of Virginia in 1990. He performed his internship at Roanoke Memorial Hospital in Virginia before moving on to his residency in ophthalmology at the Ochsner Clinic in New Orleans.
After a year of fellowship training in anterior segment surgery of the eye at the Kentucky Eye Institute, Dr. Schulze, Jr. returned home to Savannah in partnership with his father. Dr. Schulze, Jr. is a member of the American Medical Association, the American Academy of Ophthalmogy, the American Society of Cataract and Refractive Surgery, the International Society of Refractive Surgery, and the Medical Advisory Board of the Georgia Eye Bank.
Dr. Schulze, Jr. specializes in cataract and refractive surgery. Outside of ophthalmology, his interests include windsurfing, sailing, fishing, hunting, farming, and literature.
We are happy to announce that February, 2017 marks our 20th consecutive year of operation. In the 1990’s, Dr. Schulze Jr & Sr recognized the need for a venue for affordable, convenient, and high quality surgery for our cataract and refractive surgery patients.
Prior to that time, all eye surgeries were performed in the hospital, and while quality was good, the size and bureaucracy of the hospitals did not lend themselves to efficiency, and costs to the patient were roughly double (and, in some documented cases, up to ten times as high) what was spent on facility fees in the ambulatory surgery center setting. Although Dr. Schulze, Sr. had long wanted to build a surgery center, Georgia state law prevented him from doing so, mainly because the powerful hospital lobby was against any competition for their services. After all, they had a government sponsored monopoly on surgery, and could essentially charge whatever they wanted for their services.
But the laws changed in the mid ’90’s, and Dr. Schulze, Jr and Sr teamed up to build the first outpatient surgery center specializing in eye surgery in coastal Georgia. Construction took place in 1996, and we opened our doors for our first surgeries in 1997. Since that time, we’ve had the opportunity to serve tens of thousands of #cataract and #LASIK patients, saving our patient base millions of dollars in the process as compared to what they would have spent in the hospital setting. More importantly, however, we have been able to provide first class care to an entire generation of patients, and we look forward to carrying on these traditions of quality and innovation for generations to come.
The Holy Grail for eye surgeons would be to have an implant that would provide for simultaneous far and near vision–and everything between–after cataract surgery. Although multifocal intraocular lenses have been in common use now for over 20 years, they are not for everyone. Specifically, certain conditions such as astigmatism, retinal or corneal disease, and dry eye can make vision after multifocal implants less than optimal.
Last year, the Symfony intraocular lens, made by AMO, was approved by the FDA. This is the first so called extended depth of focus lens to enter the marketplace, creating a longer range of clear vision as compared to previous multifocal designs through improved optics which correct not only spherical aberration, but also chromatic aberration. Although Symfony patients might not be able to read the very smallest lines of print after surgery, we are finding that they tend to have a more effective range of vision than traditional multifocal IOl patients. Specifically, we’re finding that Symfony patients tend to excel without glasses in real world situations like seeing the dashboard while driving a car and reading a cell phone, tablet, or computer screen, whereas older designs that had more magnification at near tended not to see well with intermediate tasks.
Moreover, the Symfony lens is now available in a toric version that corrects for astigmatism at the same time as it corrects far and near vision. This enables patients who previously were not candidates for multifocal lenses to have an extended range of vision.
Is the Symfony lens the Holy Grail for cataract surgery? Well maybe not quite, but it appears to be the closest thing to it we have at our disposal today. The smiles and happy faces I see the day after surgery, with patients asking, “can I have my second eye done tomorrow” appear to be proof that this technology works.
So, here’s the deal with this EpiPen fiasco. A lot of people assume this is due solely to corporate greed and capitalism run amok. Well, that’s not the whole story. Mylen is able to raise the price of an EpiPen to unconscionable levels because excess regulation from the FDA and the government has created nearly insurmountable barriers to entry for other generic manufacturers, thus creating an effective monopoly for Mylen, so they can raise the price to whatever they want. This isn’t capitalism, this is rent seeking: effectively, a government sanctioned monopoly. With true capitalism, there would be effective competition, and in a rational world with true competition you would be able to buy an epi-pen for about 20 bucks.
As an eye surgeon, I use epinephrine every day in surgery. What does it cost me? Well, today, I was signing invoices for my surgery center and came across this invoice for 75 1 ml vials of epinephrine, for which I paid the princely sum of $1,215. Do the math: that’s $16.20 per cc of epinephrine (in fact, until recently, the cost was MUCH lower, but that’s another story). The branded Epipen that sells for $600 is sold in packs of two syringes, each with 0.3 cc of epinephrine, for a total of 0.6 cc. That 0.6 cc amounts to about $10 worth of product, yet it is sold at a markup sixty times higher!
In case anyone wonders, here’s a copy of the invoice pictured below (I’ve blacked out my DEA number and medical license number, since I don’t want my Facebook friends practicing medicine under my license….)
Don’t get me wrong: I’m a capitalist. I want to get rich. But I also want to sleep at night, and I cannot see how we as a society can permit this kind of excess regulation that stifles true competition in medicine and the pharmaceutical industry. My favorite generic manufacturer, Imprimis Pharmaceuticals, may be entering the fray with an affordable, generic epipen soon and I hope this situation will remedied.
A WaveScan is a computerized device that we use to create a “fingerprint” of your vision prior to having surgery with LASIK or PRK with the AMO/VISX Star S4 IR excimer laser. Although other people may have the same refraction as you, your WaveScan is unique to you. This technology allows us to capture your refraction, including higher order aberrations, and to upload your diagnostic data to the computer that drives the laser. Because the laser has iris recognition technology (called “iris registration” or “IR”), the laser will know the difference between your right and left eye (thus eliminating the possibility of wrong site surgery) and, after locking onto your eye, will deliver a customized treatment in the exact spot where the diagnostic data were acquired.
Carrying on our tradition of innovation in eye surgery, the Schulze Surgery Center was the first center in coastal Georgia to offer this technology. Using the WaveScan together with our AMO/VISX Star S4 IR excimer laser allows us to offer truly customized wavefront guided LASIK and PRK, called CustomVue.
Data submitted to the FDA for CustomVue LASIK found the following:
4x as many participants in the low to moderate myopia clinical study were very satisfied with their night vision after the Advanced CustomVue Procedure, compared to their night vision before with glasses or contact lenses
4x as many participants in the hyperopia clinical study were very satisfied with their night vision after the Advanced CustomVue Procedure, compared to their night vision before with glasses or contact lenses
Nearly 2x as many participants in the mixed astigmatism clinical study were very satisfied with their night vision after the Advanced CustomVue Procedure, compared to their night vision before with glasses or contact lenses
90% of patients surveyed in the high myopia clinical study were more satisfied, or as satisfied with their vision after the Advanced CustomVue Procedure as they were before with glasses or contact lenses
LASIK is an acronym for “laser assisted in situ keratomileusis.” The procedure uses the excimer laser to reshape the cornea so as to correct your nearsightedness, farsightedness, and astigmatism. With LASIK, the laser reshapes the cornea underneath a corneal flap (think of the flap as being like a trap door on the surface of the cornea) allowing for quicker healing with less pain. In fact, most of our LASIK patients are back to their normal activities the day after surgery.
Our practice began performing LASIK back in 1997. Not everyone is a candidate for LASIK, but for those who aren’t, we also perform other refractive procedures such as the ICL and Refractive Lens Exchange
